Your session is about to expire
← Back to Search
5-HT3 Receptor Antagonist
Tropisetron for Postoperative Cognitive Dysfunction
Phase 4
Waitlist Available
Research Sponsored by Beijing Chao Yang Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day before surgery and 1 month after surgery
Awards & highlights
Summary
The purpose of this study is to assess the feasibility of a randomized, double-blind, placebo-controlled pilot trial evaluating the effect of tropisetron on prevention of postoperative cognitive dysfunction in patients after cardiac surgery.
Eligible Conditions
- Postoperative Cognitive Dysfunction
- Delirium
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one day before surgery, discharge from hospital and 1 month after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day before surgery, discharge from hospital and 1 month after surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The feasibility of tropisetron intervention on POCD in patients after cardiac surgery
Secondary study objectives
EEG frequency spectrum
Functional status measurement
Incidence of postoperative cognitive dysfunction
+4 moreOther study objectives
Incidence of major adverse cardiac and cerebral events
Side effects data
From 2011 Phase 3 trial • 179 Patients • NCT004353709%
Other Adverse Event
100%
80%
60%
40%
20%
0%
Study treatment Arm
Tropisetron
Placebo
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: TropisetronExperimental Treatment1 Intervention
Patients allocated to this arm will receive intravenous Tropisetron (5mg) before anesthesia induction and once daily for 7 days after surgery.
Group II: PlaceboPlacebo Group1 Intervention
Patients allocated to this arm will receive an identical volume of normal saline before anesthesia and once daily for 7 days after surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tropisetron
2016
Completed Phase 3
~27390
Find a Location
Who is running the clinical trial?
Beijing Chao Yang HospitalLead Sponsor
212 Previous Clinical Trials
10,790,712 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger